Mesoblast Jumps Most in 4 Years as Celgene Invests $45 Million

Mesoblast Ltd. jumped the most in more than four years in Sydney trading after the developer of stem-cell therapies agreed to sell a minority stake to U.S.-based Celgene Corp. for A$58.5 million . Mesoblast traded as much as 27 percent higher at A$4.07, its biggest intraday gain since December 2010.

http://washpost.bloomberg.com/Story?docId=1376-NMPZ4J6JIJUO01-0GQTGMR37ISOQVM390LAJ2JJP1